MediArk Inc. possesses innovative porous material technology (Metal-Organic Frameworks/Covalent-Organic Frameworks) and is developing innovative products in the chemical/biotechnology fields. In addition to nano/micro particle size control, we are developing adsorbents, catalysts, vaccines, targeted treatments, synthetic drugs, and cosmeceutical cosmetics through pore control/surface modification/drug loading technologies.